Patient involvement in trial design: looking to the futureCOVID-19 has transformed the way we think about patient participation in trial design – but there are still Share XPatient involvement in trial design: looking to the futurehttps://pharmaphorum.com/patients/patient-involvement-in-trial-design-looking-to-the-future/
Inside the UK’s leading efforts to restart clinical researchA herculean national effort has seen 69% of paused studies due to COVID restarted under the National Institute Share XInside the UK’s leading efforts to restart clinical researchhttps://deep-dive.pharmaphorum.com/magazine/research-and-development-2021/inside-uks-leading-efforts-restart-clinical-research/
Deep Dive: Research and DevelopmentPharma’s historic R&D efforts have given us some light at the end of the COVID tunnel. Now it’s Share XDeep Dive: Research and Developmenthttps://pharmaphorum.com/r-d/views-analysis-r-d/deep-dive-research-and-development/
Increasing patient engagement with UK clinical trialsPharma companies face many challenges when involving patients in the design of clinical trials – but doing so Share XIncreasing patient engagement with UK clinical trialshttps://pharmaphorum.com/r-d/views-analysis-r-d/increasing-patient-engagement-with-uk-clinical-trials/
Virtual trials and the next generation of pharma clinical researchPreviously viewed as a ‘nice to have’ for the pharma industry, virtual trials were already moving from a Share XVirtual trials and the next generation of pharma clinical researchhttps://pharmaphorum.com/webinars/nihr-virtual-trials-pharma-research/
Coordinating and delivering research in the pandemic: The UK approachThe acute phase of the COVID-19 pandemic tested the UK’s capacity and capability to rapidly deliver crucial clinical Share XCoordinating and delivering research in the pandemic: The UK approachhttps://pharmaphorum.com/webinars/uk-covid-coronavirus-research-nihr/
2020 in review: COVID-19 and patient centric clinical trialsThe trials and tribulations of 2020 have brought the vital role of research, pharma, and biotech into sharp Share X2020 in review: COVID-19 and patient centric clinical trialshttps://pharmaphorum.com/views-analysis-patients/2020-in-review-covid-19-and-patient-centric-clinical-trials/
Does a lack of diversity in clinical trials reflect a lack of diversity among researchers?Embedding diversity into clinical research does not start and end at trial recruitment – the community needs processes Share XDoes a lack of diversity in clinical trials reflect a lack of diversity among researchers?https://pharmaphorum.com/views-analysis-patients/does-a-lack-of-diversity-in-clinical-trials-reflect-a-lack-of-diversity-among-researchers/
An introduction to the new NIHR National Patient Recruitment CentresA new network of patient recruitment centres is set to shape the future of commercial clinical trials in Share XAn introduction to the new NIHR National Patient Recruitment Centreshttps://pharmaphorum.com/r-d/views-analysis-r-d/an-introduction-to-the-new-nihr-national-patient-recruitment-centres/
